SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-002085
Filing Date
2019-01-18
Accepted
2019-01-18 16:17:00
Documents
1
Period of Report
2019-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv511256_4.html 4  
1 OWNERSHIP DOCUMENT tv511256_4.xml 4 4481
  Complete submission text file 0001144204-19-002085.txt   6047
Mailing Address C/O CELLECTAR BIOSCIENCES, INC. 8383 GREENWAY BLVD STE 600 MIDDLETON WI 53562
Business Address
CARUSO JAMES V (Reporting) CIK: 0001202770 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 19533414

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations